Many efforts have been made in recent
years to adopt and implement
continuous processing into the pharmaceutical production chain, driven
by the desire to optimize the process efficacy and cost as well as
the product quality. In the current challenging times, the need for
fast adaptable processes to enlarge and facilitate the drug production
on short notice is even more immanent than before. Suitable equipment
for some unit operations is still missing. Drying is one of those
and one of the most complex processes in the active pharmaceutical
ingredient (API) manufacturing chain. Drying can influence the surface
structure, particle size, as well as the morphology, in the worst
case even causing degradation, especially in heat-sensitive substances.
When producing APIs by proper design of the crystallization process
to the desired target properties, it is key to have a drying process
that can remove residual liquids without changing the particles. Practically,
this means not changing particle size distribution by neither agglomeration
nor particle attrition. In this work, the process window of a process,
enabling full-scale continuous drying of a crystalline API after crystallization
and washing, was investigated. An Ibuprofen paste containing water
and ethanol as a liquid phase has been dried in a continuous vacuum
dryer. The particles undergo no change during the process, and the needle-shaped particle
form as well as the volume mean diameter of ∼80 μm was
maintained until the end of the process for a large process window.
Furthermore, it was shown that this continuous process can be run
successfully in a semicontinuous mode, which enables implementing
this new process into the existing batch operating manufacturing plants.
The process time is much faster as for conventional batch drying technology,
and the product volume can be scaled via run time or the throughput,
therefore enabling a fast response to change in drug demand.